We are live on ! Find out more
QM

QVIDTVM Management Portfolio holdings

AUM $76.6M Turnover 13.33%
1-Year Est. Return 33.48%
This Fund
S&P 500
This Quarter Est. Return
-6.43%
1 Year Est. Return
+33.48%
3 Year Est. Return
+19.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$81.4M
AUM Growth
-$7.01M
Cap. Flow
-$763K
Cap. Flow %
-0.94%
Top 10 Hldgs %
98.4%
Holding
16
New
3
Increased
4
Reduced
3
Closed
2
Avg Time Held
1.4 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.4 years

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$6.32M
2
NBIS icon
Nebius Group N.V.
NBIS
+$2.59M
3
HRB icon
H&R Block
HRB
+$810K
4
ZGN icon
Zegna
ZGN
+$517K
5
PM icon
Philip Morris
PM
+$187K

Top Sells

Rank Stock Value
1
COTY icon
Coty
COTY
+$4.67M
2
EQIX icon
Equinix
EQIX
+$3.39M
3
SOLV icon
Solventum
SOLV
+$1.86M
4
XRAY icon
Dentsply Sirona
XRAY
+$1.25M
5
WAB icon
Wabtec
WAB
+$153K

Sector Composition

Rank Sector Weight
1 Healthcare 55.75%
2 Materials 14.97%
3 Communication Services 7.74%
4 Consumer Discretionary 7.64%
5 Technology 7.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BIO icon
1
Bio-Rad Laboratories Class A
BIO
$9.58B
$23.3M 28.68%
83,732
+249
+0.3% +$71.7K
2023 Q3
10 quarters
SOLV icon
2
Solventum
SOLV
$14.8B
$17.3M 21.32%
265,615
-25,000
-9% -$1.86M
2024 Q1
8 quarters
AMRZ icon
3
Amrize Ltd
AMRZ
$20.8B
$12.2M 14.97%
217,456
+900
+0.4% +$51.6K
2025 Q4
1 quarter
NBIS icon
4
Nebius Group N.V.
NBIS
$47.4B
$6.3M 7.74%
60,678
+25,978
+75% +$2.59M
2025 Q4
1 quarter
ORCL icon
5
Oracle
ORCL
$396B
$5.72M 7.03%
+38,902
New +$6.32M
2026 Q1
0 quarters
ZGN icon
6
Zegna
ZGN
$3.51B
$5.48M 6.73%
525,893
+50,000
+11% +$517K
2024 Q3
6 quarters
XRAY icon
7
Dentsply Sirona
XRAY
$1.76B
$4.47M 5.49%
385,409
-100,000
-21% -$1.25M
2024 Q1
8 quarters
BRCC icon
8
BRC Inc
BRCC
$150M
$2.64M 3.24%
340,068
– –
2023 Q1
12 quarters
ARE icon
9
Alexandria Real Estate Equities
ARE
$7.26B
$1.86M 2.28%
40,000
– –
2025 Q4
1 quarter
HRB icon
10
H&R Block
HRB
$5.88B
$738K 0.91%
+23,255
New +$810K
2026 Q1
0 quarters
WAB icon
11
Wabtec
WAB
$49B
$692K 0.85%
2,770
-634
-19% -$153K
2021 Q4
17 quarters
RTO icon
12
Rentokil
RTO
$10.6B
$217K 0.27%
6,879
– –
2022 Q4
13 quarters
LAB icon
13
Standard BioTools
LAB
$254M
$211K 0.26%
229,338
– –
2025 Q4
1 quarter
PM icon
14
Philip Morris
PM
$319B
$178K 0.22%
+1,079
New +$187K
2026 Q1
0 quarters
COTY icon
15
Coty
COTY
$2.86B
– –
-1,515,888
Closed -$4.67M –
EQIX icon
16
Equinix
EQIX
$98.1B
– –
-4,426
Closed -$3.39M –

Similar funds

QVIDTVM Management's Q1 2026 Portfolio in Review

As of Q1 2026, QVIDTVM Management held 16 positions worth $81.4M, down 7.9% from $88.4M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

QVIDTVM Management's Q1 2026 filing shows 3 new, 4 increased, 3 reduced and 2 closed positions. Its largest new stake was Oracle: 38,902 shares worth $5.72M. The largest sale was Coty, an estimated $4.67M.

By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 61% a quarter earlier, followed by Materials and Communication Services.

  • QVIDTVM Management's largest Q1 2026 buy was Oracle: 38,902 shares worth $5.72M.
  • QVIDTVM Management added most to Nebius Group N.V. in Q1 2026, an estimated $2.59M increase.
  • QVIDTVM Management's biggest Q1 2026 reduction was Solventum, cutting an estimated $1.86M.
  • QVIDTVM Management fully exited Coty in Q1 2026, selling an estimated $4.67M.
  • QVIDTVM Management's ten largest holdings make up 98% of its $81.4M portfolio in Q1 2026.
  • QVIDTVM Management opened 3 new positions and closed 2 in Q1 2026.
  • QVIDTVM Management's portfolio value fell 7.9% quarter-over-quarter to $81.4M.

Based on QVIDTVM Management's 13F filing for Q1 2026, filed 15 May 2026.